Gabriel Ángel Martos‐Moreno

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials

Karine Clément, Erica L T van den Akker, Jesús Argente et al. · The Lancet Diabetes & Endocrinology · 2020 · 463 citations

Medicine, Endocrinology, Pharmacology +15

Mutations in pregnancy‐associated plasma protein A2 cause short stature due to low IGF‐I availability

Andrew Dauber, M.T. Muñoz-Calvo, Vicente Barrios et al. · EMBO Molecular Medicine · 2016 · 212 citations · Full text

Medicine, Genetics, Molecular Biology +17

Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period

Andrea M. Haqq, Wendy K. Chung, Hélène Dollfus et al. · The Lancet Diabetes & Endocrinology · 2022 · 182 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency

Jesús Argente, Raquel Flores, Armand Gutiérrez‐Arumí et al. · EMBO Molecular Medicine · 2014 · 117 citations · Full text

Life Sciences, Endocrinology, Genetics +15

Influence of prematurity and growth restriction on the adipokine profile, IGF1, and ghrelin levels in cord blood: relationship with glucose metabolism

Gabriel Ángel Martos‐Moreno, Vicente Barrios, Jesús Pozo et al. · European Journal of Endocrinology · 2009 · 99 citations · Full text

Medicine, Endocrinology, Pediatrics +17